On this page
What each program costs in New Hampshire
The monthly price is all-in: the drug plus a membership when we have verified one. Compounded drugs are not FDA-approved.
| # | Program | Cheapest product | Plan | All in | Membership fee | Trustpilot | Checked | Seller site |
|---|---|---|---|---|---|---|---|---|
| 1 | Compounded Semaglutide | sale price | $39/mo | not verified | too few reviews | Visit | ||
| 2 | Compounded Semaglutide | 12-month plan, $588 up front | $49/mo | none | 3.9 (11,798 reviews) | Visit | ||
| 3 | Compounded Semaglutide | month to month | $59/mo | none | too few reviews | Visit | ||
| 4 | Compounded Semaglutide | 12-month plan, $828 up front | $69/mo | none | 4.6 (4,268 reviews) | Visit | ||
| 5 | Compounded Semaglutide | medication monthly, membership yearly | $75/mo | $199/yr, included | 4.8 (288 reviews) | Visit | ||
| 6 | Compounded Semaglutide | month to month | $79/mo | none | too few reviews | Visit | ||
| 7 | Compounded Semaglutide | month to month | $99/mo | none | 4.6 (5,235 reviews) | Visit | ||
| 8 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.3 (880 reviews) | Visit | ||
| 9 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.2 (218 reviews) | Visit | ||
| 10 | Compounded Semaglutide | 12-month plan, $1,260 up front | $105/mo | none | too few reviews | Visit | ||
| 11 | Compounded Semaglutide | 12-month plan, $1,698 up front | $141/mo | none | too few reviews | Visit | ||
| 12 | Semaglutide | month to month | $149/mo | none | too few reviews | Visit | ||
| 13 | Compounded Semaglutide | 12-month plan, $1,788 up front | $149/mo | none | 4.2 (777 reviews) | Visit | ||
| 14 | Microdosing Tirzepatide | 12-month plan, $2,028 up front | $169/mo | none | 4.0 (162 reviews) | Visit | ||
| 15 | Compounded Semaglutide | 2-month plan, $350 up front | $175/mo | none | 4.6 (1,084 reviews) | Visit | ||
| 16 | Compounded Oral Semaglutide Capsules | 6-month plan, $1,194 up front | $199/mo | none | too few reviews | Visit | ||
| 17 | Foundayo (brand orforglipron) | medication monthly, membership yearly | $208/mo | $59/mo, billed yearly, included | 4.6 (4,607 reviews) | Visit | ||
| 18 | Sublingual Semaglutide | month to month | $249/mo | none | 4.5 (17,622 reviews) | Visit | ||
| 19 | Compounded Semaglutide | month to month | $299/mo | none | too few reviews | Visit |
Does the State of New Hampshire Health Benefit Plan cover GLP-1s for weight loss?
New Hampshire's Department of Administrative Services told the Governor and Council in August 2025 that the State Health Benefit Plan does not cover GLP-1 medications for weight loss.
Does New Hampshire Medicaid cover GLP-1s for weight loss?
Not covered for weight loss
New Hampshire Medicaid stopped covering GLP-1 medications prescribed solely for weight loss, including Wegovy and Zepbound, on January 1, 2026. Read from state documents Nov 6, 2026.
What New Hampshire Medicaid's documents say about each drug for weight loss. Read Nov 6, 2026. New Hampshire Department of Health and Human Services, Division of Medicaid Services.
WegovyNo
Still covered for other conditions such as heart event risk or a liver condition (MASH), with prior authorization.
“GLP-1 medications (such as Saxenda, Wegovy, and Zepbound and any generic versions) will no longer be reimbursed by Medicaid if prescribed exclusively for weight loss purposes.”
New Hampshire DHHS, Division of Medicaid Services · Effective Jan 1, 2026 · read Nov 6, 2026
ZepboundNo
Still covered for moderate to severe sleep apnea with prior authorization, BMI 27 or higher.
“GLP-1 medications (such as Saxenda, Wegovy, and Zepbound and any generic versions) will no longer be reimbursed by Medicaid if prescribed exclusively for weight loss purposes.”
New Hampshire DHHS, Division of Medicaid Services · Effective Jan 1, 2026 · read Nov 6, 2026
“Patient is using Zepbound solely for chronic weight management.”
New Hampshire Medicaid FFS, via Prime Therapeutics · No effective date on the document · read Nov 6, 2026
OzempicNo
Covered under GLP-1 criteria that require a type 2 diabetes diagnosis.
“Effective January 1, 2026, New Hampshire Medicaid will no longer cover GLP-1 medications when prescribed solely for weight loss.”
New Hampshire DHHS, Division of Medicaid Services · Effective Jan 1, 2026 · read Nov 6, 2026
“Patient has a diagnosis of a type 2 diabetes mellitus; AND”
New Hampshire Medicaid FFS, via Prime Therapeutics · No effective date on the document · read Nov 6, 2026
MounjaroNo
Covered under GLP-1 criteria that require a type 2 diabetes diagnosis.
“Effective January 1, 2026, New Hampshire Medicaid will no longer cover GLP-1 medications when prescribed solely for weight loss.”
New Hampshire DHHS, Division of Medicaid Services · Effective Jan 1, 2026 · read Nov 6, 2026
“Patient has a diagnosis of a type 2 diabetes mellitus; AND”
New Hampshire Medicaid FFS, via Prime Therapeutics · No effective date on the document · read Nov 6, 2026
This reports what the documents say. It is not medical or legal advice: your plan and your prescriber decide.
What changed, and when
- Nov 6, 2026 · This pageFirst read from New Hampshire Department of Health and Human Services, Division of Medicaid Services documents. KFF's January 2026 map listed this program as not covered; the documents we read agree.
- Jan 1, 2026 · Policy changeStopped covering GLP-1 medications prescribed solely for weight loss.
“Effective January 1, 2026, New Hampshire Medicaid will no longer cover GLP-1 medications when prescribed solely for weight loss.”
New Hampshire DHHS, Division of Medicaid Services · Effective Jan 1, 2026 · read Nov 6, 2026
Weight loss
Not covered, read Nov 2026
Type 2 diabetes
Required in every state
Heart risk, sleep apnea
Required (Wegovy, Zepbound)
Prior authorization
Typical when covered
Wegovy, Zepbound, Saxenda, 2025
19,697 prescriptions
Ozempic and Mounjaro, 2025
11,148 prescriptions
Neighbours covering weight loss
0 of 3
Federal law lets each state decide whether Medicaid pays for drugs used for weight loss, while drugs approved for diabetes must be covered. A state document may not settle every plan; if your New Hampshire Medicaid coverage comes through a managed care plan, its formulary can differ, so ask the plan before you fill.
For comparison, a dated secondary source: KFF's January 2026 map listed New Hampshire Medicaid as "not covered" for GLP-1s for obesity under fee-for-service. New Hampshire covered GLP-1s for obesity in October 2025 and had ended that coverage by January 2026. New Hampshire Medicaid covers one or more older weight-loss drugs, but no GLP-1.
The BALANCE model
CMS’s BALANCE model lets state Medicaid programs add GLP-1s for weight management at a negotiated price. States could join on a rolling basis from May 1, 2026 through January 1, 2027, and the state application deadline was July 31, 2026. We could not find a published list of the states that joined, so this page does not say whether New Hampshire Medicaid did. Ask your plan. Either way your cost stays at Medicaid’s nominal copay, which BALANCE does not change.
The national picture, coupons and patient assistance: does Medicaid cover GLP-1s.
How many GLP-1s does New Hampshire Medicaid pay for?
34,652 GLP-1 prescriptions in 2025, 41st of the 50 states and DC, with $37.5 million reimbursed before rebates.
Prescriptions, 2025
34,652
41st of 51
Medicaid paid
$37.5M
39th of 51, before rebates
Per prescription
$1,082
$1,051 nationally
Weight-loss brands
57%
5th highest share of 51
CMS State Drug Utilization Data 2025, updated Jul 13, 2026, fee-for-service and managed care, before rebates. New Hampshire is highlighted. CMS publishes this comparison as one year, not a trend.
Wegovy, Zepbound and Saxenda, the brands approved for weight management, were 57% of New Hampshire Medicaid's GLP-1 prescriptions in 2025 (19,697). Across the 13 states KFF lists as covering GLP-1s for obesity, the median share was 52%; across the other 38, 2.3%. Where weight loss is not covered, those brands are mostly filled for the uses Medicaid must cover, such as heart risk and sleep apnea. Wegovy was New Hampshire Medicaid's most filled GLP-1.
| Brand | Prescriptions | Share | Medicaid paid | Per Rx |
|---|---|---|---|---|
| Wegovyapproved for weight management | 12,961 | 37% | $16.4 million | $1,262 |
| Ozempic | 8,301 | 24% | $8.1 million | $974 |
| Zepboundapproved for weight management | 6,455 | 19% | $6.4 million | $993 |
| Trulicity | 3,203 | 9.2% | $3.2 million | $989 |
| Mounjaro | 2,847 | 8.2% | $2.7 million | $962 |
| Liraglutide (generic) | 361 | 1.0% | $165,444 | $458 |
| Saxendaapproved for weight management | 281 | 0.8% | $311,425 | $1,108 |
| Rybelsus | 230 | 0.7% | $242,251 | $1,053 |
| Victoza | 13 | 0.0% | $9,051 | $696 |
Source: CMS State Drug Utilization Data 2025, updated Jul 13, 2026, all four quarters, fee-for-service and managed care. Before rebates. CMS suppresses rows under 11 prescriptions, so small brands are undercounted slightly. Every state ranked: prescriptions and spending.
On Medicare in New Hampshire?
Medicare’s temporary GLP-1 Bridge works the same in every state: a $50 copay for a one-month supply of Wegovy, Foundayo or the Zepbound KwikPen, for people with Part D who meet its weight and health rules.
medicare.gov
“You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug).”
https://www.medicare.gov/coverage/weight-loss-drugs · read Nov 14, 2026
New Hampshire and the states around it
Medicaid’s weight-loss answer (the state’s own documents where we have read them, otherwise KFF, January 2026) and the partner programs that ship there, priced the same way as above.
None of the 3 states next to New Hampshire covers GLP-1s for weight loss through Medicaid. None has a lower cash floor than New Hampshire's $39.
| State | Medicaid, weight loss | Ship there | Cheapest that ships there |
|---|---|---|---|
| New Hampshire | Not covered | 19 | $39/mo |
| Maine | Not covered | 19 | $39/moWellmedr |
| Massachusetts | Not covered | 18 | $39/moWellmedr |
| Vermont | Not covered | 19 | $39/moWellmedr |






















